Market Tracker

04/17 6:05pm ET

Exelixis Inc (NASDAQ:EXEL)

3.29
Data as of Apr 17
 -0.03 / -0.90%
Today’s Change
3.02
Today|||52-Week Range
8.41
-46.33%
Year-to-Date

Today’s Trading

Previous close3.32
Today’s open3.28
Day’s range3.26 - 3.44
Volume2,689,098
Average volume (3 months)5,450,596
Market cap$692.8M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-13.05%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Research C...+0.38+3.07%
BRLIBio-Reference Labora...-0.19-0.69%
NXTMNxStage Medical Inc-0.07-0.53%
LXRXLexicon Pharmaceutic...+0.08+5.16%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 6, 2014
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Frank L. Karbe
Corporate headquarters
South San Francisco, California

Forecasts